PMC:7600245 / 21697-21986
Annnotations
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T78 | 94-102 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
T79 | 105-114 | Disease | denotes | infection | http://purl.obolibrary.org/obo/MONDO_0005550 |
T80 | 247-255 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T200 | 59-60 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T201 | 137-138 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T291 | 16-29 | Chemical | denotes | emtricitabine | http://purl.obolibrary.org/obo/CHEBI_31536 |
T292 | 34-55 | Chemical | denotes | tenofovir alafenamide | http://purl.obolibrary.org/obo/CHEBI_90926 |
T293 | 34-43 | Chemical | denotes | tenofovir | http://purl.obolibrary.org/obo/CHEBI_134504|http://purl.obolibrary.org/obo/CHEBI_63625|http://purl.obolibrary.org/obo/CHEBI_63716 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T159 | 0-289 | Sentence | denotes | The efficacy of emtricitabine and tenofovir alafenamide as a prophylactic combination against SARS-CoV-2 infection is being evaluated in a large randomized, double-blind, controlled with placebo clinical trial for health care providers exposed to COVID-19 patients (NCT04405271; n = 1378). |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
564 | 256-264 | Species | denotes | patients | Tax:9606 |
578 | 16-29 | Chemical | denotes | emtricitabine | MESH:D000068679 |
579 | 34-55 | Chemical | denotes | tenofovir alafenamide | MESH:C442442 |
584 | 94-114 | Disease | denotes | SARS-CoV-2 infection | MESH:C000657245 |
585 | 247-255 | Disease | denotes | COVID-19 | MESH:C000657245 |